At the Bausch + Lomb booth, discover the ELIOSTM System. Backed by 10 clinical studies across 588 treated eyes, ELIOS has demonstrated up to 29–43% IOP reduction and up to 82% of patients medication-free at one year, with outcomes tracked up to 8 years post-op. Meet our experts and explore how ELIOS integrates with routine cataract surgery to address glaucoma early, safely, and effectively.
Mark your calendars for 30 May – 2 June 2026 in Brussels, and register now to secure your place at one of the most important gatherings in European ophthalmology.
